Public Release: 

Future Science Group showcases UK Parkinson's Excellence Network

A new effort to improve treatment

Future Science Group


IMAGE: This is the journal cover. view more

Credit: Future Science Group

The newly launched UK Parkinson's Excellence Network can transform care for those affected by Parkinson's, according to an article in Neurodegenerative Disease Management. The journal, published by Future Science Group, features a detailed review of the multi-disciplinary effort, which brings together health professionals, social care experts, Parkinson's UK, and patients, to develop and advocate for more patient-centered care for those affected by Parkinson's in the United Kingdom.

"We formed this network to fundamentally improve the care provided to people with Parkinson's, from the point of diagnosis onwards," said Professor David Burn, Consultant Neurologist, author of the article and clinical director of the Excellence Network. "By bringing together patients, their caregivers, experts in both the clinical treatment and social services, and the resources of Parkinson's UK, the largest charity funder of Parkinson's research in Europe, we believe we can drive a fundamental change in patient care."

The article provides details on the Excellence Network's six themed working groups, which focus on leading improvement in subject areas such as education or service development. The Excellence Network also supports 20 regional working groups, which seek to empower and support both patients and professionals to build awareness and drive changes in their local area.

"The aim is to raise our voices so the need for better care is recognized, and to raise the level of service consistency, so that every person with Parkinson's receives a high-quality standard of care, and every professional can make better use of their time and effort," said Professor Burn.

"Prof. Burn provides extensive detail on this new effort, developed in direct response to the requests of those living with Parkinson's disease, to disseminate successful Parkinson's care strategies throughout the UK," said Daphne Boulicault, Editor of Neurodegenerative Disease Management. "This is a practical first step towards a nationwide, multidisciplinary and patient-centered Parkinson's service."

Parkinson's is a progressive neurological condition for which there is currently no cure. In the UK, one person in every 500, or about 127,000 people, has Parkinson's.


To view the articles:



Additional articles and cancer content can be found on Neurology Central, Future Science Group's free eCommunity for neurology professionals. The membership-based portal offers free access to breaking neurology news and peer-reviewed journal articles, with content selected by fellow clinicians.

About Parkinson's UK

Parkinson's UK is the UK's leading charity supporting those with the condition. Its mission is to find a cure and improve life for everyone affected by Parkinson's through cutting edge research, information, support and campaigning.

For advice, information and support, visit or call our free, confidential helpline on 0808 800 0303.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.